Product Description
FXR agonist (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01998659)
Mechanisms of Action: FXR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Phenex AG
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01998672 |
PHS-Px-102-I-02 | P1 |
Completed |
Healthy Volunteers |
2012-10-01 |
2019-03-20 |
Treatments |
|
NCT01998659 |
PHS-Px-102-I-01 | P1 |
Completed |
Healthy Volunteers |
2011-12-01 |
2019-03-20 |
Treatments |